{"disease":{"id":"diabetic-macular-oedema","name":"diabetic macular oedema"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06985706","title":"Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser for Treating Severe Diabetic Macular Oedema When the Central Retina Goes <400 Microns","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":264,"lead_sponsor_name":"Belfast Health and Social Care Trust","has_results":false},{"nct_id":"NCT02731911","title":"Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study","phase":"","overall_status":"COMPLETED","enrollment_count":202,"lead_sponsor_name":"Allergan","has_results":false},{"nct_id":"NCT06908876","title":"A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema（DME）","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Innovent Biologics Technology Limited (Shanghai R&D Center)","has_results":false},{"nct_id":"NCT04576689","title":"Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - a Sustained, Low Dose Dexamethasone Therapy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Ripple Therapeutics Pty Ltd","has_results":false},{"nct_id":"NCT02181400","title":"Near Infrared Photobiomodulation Treatment for Diabetic Macular Oedema","phase":"NA","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"University of Sydney","has_results":true}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}